Charles Schwab’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.1M | Buy |
1,417,711
+84,329
| +6% | +$2.74M | 0.01% | 1155 |
|
|
2025
Q1 | $50.3M | Sell |
1,333,382
-8,391
| -0.6% | -$317K | 0.01% | 1064 |
|
|
2024
Q4 | $110M | Buy |
1,341,773
+45,936
| +4% | +$3.76M | 0.02% | 611 |
|
|
2024
Q3 | $148M | Buy |
1,295,837
+419,600
| +48% | +$47.9M | 0.03% | 470 |
|
|
2024
Q2 | $66.2M | Buy |
876,237
+42,619
| +5% | +$3.22M | 0.01% | 863 |
|
|
2024
Q1 | $56.9M | Buy |
833,618
+103,180
| +14% | +$7.05M | 0.01% | 944 |
|
|
2023
Q4 | $45.9M | Buy |
730,438
+17,570
| +2% | +$1.1M | 0.01% | 1035 |
|
|
2023
Q3 | $36.3M | Buy |
712,868
+104,398
| +17% | +$5.32M | 0.01% | 1111 |
|
|
2023
Q2 | $30.4M | Buy |
608,470
+120,837
| +25% | +$6.03M | 0.01% | 1202 |
|
|
2023
Q1 | $18.3M | Sell |
487,633
-846
| -0.2% | -$31.7K | 0.01% | 1541 |
|
|
2022
Q4 | $23.4M | Buy |
488,479
+143,253
| +41% | +$6.87M | 0.01% | 1326 |
|
|
2022
Q3 | $8.29M | Buy |
345,226
+55,579
| +19% | +$1.33M | ﹤0.01% | 1947 |
|
|
2022
Q2 | $6.3M | Buy |
289,647
+27,356
| +10% | +$595K | ﹤0.01% | 2085 |
|
|
2022
Q1 | $6.34M | Buy |
262,291
+19,972
| +8% | +$482K | ﹤0.01% | 2167 |
|
|
2021
Q4 | $5.77M | Buy |
242,319
+4,571
| +2% | +$109K | ﹤0.01% | 2278 |
|
|
2021
Q3 | $6.03M | Buy |
237,748
+65,145
| +38% | +$1.65M | ﹤0.01% | 2282 |
|
|
2021
Q2 | $3.89M | Buy |
172,603
+36,425
| +27% | +$820K | ﹤0.01% | 2470 |
|
|
2021
Q1 | $2.69M | Buy |
136,178
+18,585
| +16% | +$367K | ﹤0.01% | 2574 |
|
|
2020
Q4 | $3.13M | Buy |
117,593
+1,528
| +1% | +$40.6K | ﹤0.01% | 2449 |
|
|
2020
Q3 | $5.73M | Buy |
+116,065
| New | +$5.73M | ﹤0.01% | 1997 |
|